
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5236053
[patent_doc_number] => 20070128209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'VACCINE BASED METHOD FOR PROTECTION AGAINST HIV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/309193
[patent_app_country] => US
[patent_app_date] => 2006-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4012
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128209.pdf
[firstpage_image] =>[orig_patent_app_number] => 11309193
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/309193 | VACCINE BASED METHOD FOR PROTECTION AGAINST HIV INFECTION | Jul 11, 2006 | Abandoned |
Array
(
[id] => 4711975
[patent_doc_number] => 20080300501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Fluid Analyser'
[patent_app_type] => utility
[patent_app_number] => 11/995698
[patent_app_country] => US
[patent_app_date] => 2006-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2268
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300501.pdf
[firstpage_image] =>[orig_patent_app_number] => 11995698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995698 | Fluid Analyser | Jul 5, 2006 | Abandoned |
Array
(
[id] => 5580556
[patent_doc_number] => 20090175902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant'
[patent_app_type] => utility
[patent_app_number] => 12/160583
[patent_app_country] => US
[patent_app_date] => 2006-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23646
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20090175902.pdf
[firstpage_image] =>[orig_patent_app_number] => 12160583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/160583 | Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant | Jun 26, 2006 | Abandoned |
Array
(
[id] => 5367179
[patent_doc_number] => 20090304738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Methods for Enhancing Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 11/922427
[patent_app_country] => US
[patent_app_date] => 2006-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 31530
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11922427
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/922427 | Methods for Enhancing Immune Responses | Jun 14, 2006 | Abandoned |
Array
(
[id] => 8548330
[patent_doc_number] => 08323207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-04
[patent_title] => 'Method and device for measurement of exhaled respiratory gas temperature'
[patent_app_type] => utility
[patent_app_number] => 11/996963
[patent_app_country] => US
[patent_app_date] => 2006-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 4677
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11996963
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996963 | Method and device for measurement of exhaled respiratory gas temperature | Jun 11, 2006 | Issued |
Array
(
[id] => 5887725
[patent_doc_number] => 20060275323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Particles of HCV envelope proteins: use for vaccination'
[patent_app_type] => utility
[patent_app_number] => 11/445274
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 17639
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11445274
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/445274 | Particles of HCV envelope proteins: use for vaccination | Jun 1, 2006 | Abandoned |
Array
(
[id] => 4959718
[patent_doc_number] => 20080274143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Chloroplasts Engineering to Express Pharmaceutical Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/915666
[patent_app_country] => US
[patent_app_date] => 2006-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 66288
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274143.pdf
[firstpage_image] =>[orig_patent_app_number] => 11915666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/915666 | Chloroplasts Engineering to Express Pharmaceutical Proteins | May 29, 2006 | Abandoned |
Array
(
[id] => 836851
[patent_doc_number] => 07393666
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-01
[patent_title] => 'Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/440177
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22831
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/393/07393666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11440177
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/440177 | Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis | May 23, 2006 | Issued |
Array
(
[id] => 5538738
[patent_doc_number] => 20090220543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Expression of Proteins in Plants'
[patent_app_type] => utility
[patent_app_number] => 11/912912
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11078
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912912 | Expression of proteins in plants | May 1, 2006 | Issued |
Array
(
[id] => 5538738
[patent_doc_number] => 20090220543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Expression of Proteins in Plants'
[patent_app_type] => utility
[patent_app_number] => 11/912912
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11078
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912912 | Expression of proteins in plants | May 1, 2006 | Issued |
Array
(
[id] => 5270890
[patent_doc_number] => 20090074666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Peptide vaccine for influenza virus'
[patent_app_type] => utility
[patent_app_number] => 11/918791
[patent_app_country] => US
[patent_app_date] => 2006-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 72
[patent_no_of_words] => 26446
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074666.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918791
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918791 | Peptide vaccine for influenza virus | Apr 19, 2006 | Abandoned |
Array
(
[id] => 5508429
[patent_doc_number] => 20090081636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'Pharmaceutical compositions for and methods of inhibiting HCV replication'
[patent_app_type] => utility
[patent_app_number] => 11/401408
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 92062
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11401408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/401408 | Pharmaceutical compositions for and methods of inhibiting HCV replication | Apr 10, 2006 | Abandoned |
Array
(
[id] => 4728216
[patent_doc_number] => 20080207760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Pharmaceutical Compositions For and Methods of Inhibiting Hcv'
[patent_app_type] => utility
[patent_app_number] => 11/911330
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 92416
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911330
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911330 | Pharmaceutical Compositions For and Methods of Inhibiting Hcv | Apr 10, 2006 | Abandoned |
Array
(
[id] => 10001648
[patent_doc_number] => 09045727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Virus-like particles, methods of preparation, and immunogenic compositions'
[patent_app_type] => utility
[patent_app_number] => 11/397830
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 23
[patent_no_of_words] => 23357
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11397830
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397830 | Virus-like particles, methods of preparation, and immunogenic compositions | Apr 3, 2006 | Issued |
Array
(
[id] => 4845503
[patent_doc_number] => 20080181911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response'
[patent_app_type] => utility
[patent_app_number] => 11/909351
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 47779
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181911.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909351
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909351 | Use Of An Influenza Virus, An Oil-In-Water Emulsion Adjuvant, To Induce Cd4 T-Cell And/Or Improved B-Memory Cell Response | Mar 20, 2006 | Abandoned |
Array
(
[id] => 4921917
[patent_doc_number] => 20080070232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-20
[patent_title] => 'Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression'
[patent_app_type] => utility
[patent_app_number] => 11/576005
[patent_app_country] => US
[patent_app_date] => 2005-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 2886
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20080070232.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576005
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576005 | Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression | Mar 16, 2006 | Issued |
Array
(
[id] => 5760067
[patent_doc_number] => 20060211012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'MHC CLASS II AS A PREVENTIVE VACCINE AGAINST HIV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/307951
[patent_app_country] => US
[patent_app_date] => 2006-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2061
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211012.pdf
[firstpage_image] =>[orig_patent_app_number] => 11307951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/307951 | MHC CLASS II AS A PREVENTIVE VACCINE AGAINST HIV INFECTION | Feb 27, 2006 | Abandoned |
Array
(
[id] => 8213314
[patent_doc_number] => 08192747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-05
[patent_title] => 'Live attenuated rotavirus vaccine for oral administration'
[patent_app_type] => utility
[patent_app_number] => 11/816443
[patent_app_country] => US
[patent_app_date] => 2006-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 32193
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/192/08192747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816443
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816443 | Live attenuated rotavirus vaccine for oral administration | Feb 14, 2006 | Issued |
Array
(
[id] => 5337898
[patent_doc_number] => 20090054362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/816236
[patent_app_country] => US
[patent_app_date] => 2006-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12018
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054362.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816236 | COMPOUNDS | Feb 14, 2006 | Abandoned |
Array
(
[id] => 5446075
[patent_doc_number] => 20090047301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Papillomavirus L2 N-Terminal Peptides for the Induction of Broadly Cross-Neutralizing Antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/883495
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 59572
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047301.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883495
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883495 | Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies | Jan 31, 2006 | Issued |